 |
| About us |
|
| Sanofi-aventis U.S., based in Bridgewater, NJ, and employing 15,000 people across the country, is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people’s lives. Our extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders and vaccines.
|
|
|
| Quick Links |
|
|
|
| Latest News |
|
| October 30, 2009 |
| Sanofi-aventis Delivers a Solid Performance in Third Quarter 2009 |
|
|
|
|
| October 29, 2009 |
| Sanofi-aventis U.S. Appoints Patrick McLain Vice President, U.S. Federal Government Affairs and Policy |
|
|
|
|
| October 16, 2009 |
| FDA Approves Elitek® (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy |
|
|
|
|
| September 29, 2009 |
| Sanofi-aventis launches major insulin research program in partnership with the international scientific community |
|
|
|
|
